Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline RTX Q1 2026 Earnings EPS Surges Past Estimates with 161 Beat ABNB Q1 2026 Earnings EPS Misses Estimates Amid Mixed Performance EPAC Q1 2026 Earnings Slight EPS Miss Despite Strong Stock Response SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges